We have previously described that treatment of SH-SY5Y neuroblastoma cells with Aβ42 influences Reelin expression and induces changes in Reelin glycosylation that resemble Reelin glycoforms observed in AD brain [11]. This evidence concerns the gene RELN and Alzheimer disease.